Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2009 Oct 3;8(1):36–41.e1. doi: 10.1016/j.cgh.2009.09.030

Table 2.

The outcomes of concomitant and sequential therapies

Concomitant therapy Sequential therapy p-value
Eradication rate
Intention-to-treat 107/115 (93%) 108/117 (92.3%) 0.83
 Per-protocol 107/115(93%) 108/116 (93.1%) 0.99
Compliance 113/115 (98.2%) 112/117 (95.7%) 0.26
Side effect 31/115 (26.9%) 36/117 (30.7%) 0.40
 Diarrhea 3/115 (2.6%) 2/117 (1.7%) 0.64
 Constipation 0 0 -
 Abdominal pain 3/115 (2.6%) 5/117 (4.3%) 0.49
 Anorexia 4/115 (3.5%) 2/117 (1.7%) 0.40
 Nausea 9/115 (7.8%) 3/117 (2.6%) 0.07
 Vomiting 2/115 (1.7%) 2/117 (1.7%) 0.99
 Skin rash 3/115 (2.6%) 1/117 (0.8%) 0.30
 Headache 5/115 (4.3%) 5/117 (4.3%) 0.98
 Dizziness 13/115 (11.3%) 10/117(8.5%) 0.48
 Bad taste 18/115 (15.7%) 12/117 (10.3%) 0.22
 Fatigue 5/115 (4.3%) 13/117 (11.1%) 0.05